FR2434622B1 - - Google Patents

Info

Publication number
FR2434622B1
FR2434622B1 FR7921975A FR7921975A FR2434622B1 FR 2434622 B1 FR2434622 B1 FR 2434622B1 FR 7921975 A FR7921975 A FR 7921975A FR 7921975 A FR7921975 A FR 7921975A FR 2434622 B1 FR2434622 B1 FR 2434622B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7921975A
Other languages
French (fr)
Other versions
FR2434622A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of FR2434622A1 publication Critical patent/FR2434622A1/en
Application granted granted Critical
Publication of FR2434622B1 publication Critical patent/FR2434622B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7921975A 1978-09-04 1979-09-03 AMINO ACID SOLUTIONS FOR THE FEEDING OF CANCER PATIENTS Granted FR2434622A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10874978A JPS5535049A (en) 1978-09-04 1978-09-04 Amino acid transfusion for cancerous patient

Publications (2)

Publication Number Publication Date
FR2434622A1 FR2434622A1 (en) 1980-03-28
FR2434622B1 true FR2434622B1 (en) 1983-04-15

Family

ID=14492527

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7921975A Granted FR2434622A1 (en) 1978-09-04 1979-09-03 AMINO ACID SOLUTIONS FOR THE FEEDING OF CANCER PATIENTS

Country Status (10)

Country Link
JP (1) JPS5535049A (en)
AU (1) AU526207B2 (en)
CA (1) CA1134275A (en)
CH (1) CH642541A5 (en)
DE (1) DE2935709C2 (en)
FR (1) FR2434622A1 (en)
GB (1) GB2029220B (en)
IT (1) IT1194844B (en)
NL (1) NL190266C (en)
SE (1) SE448679B (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58500526A (en) * 1981-04-17 1983-04-07 アメリカン　ホスピタル　サプライ　コ−ポレ−シヨン Improved solutions for parenteral nutrition
FR2508797B1 (en) * 1981-07-03 1986-03-14 Charles Chany MEDICINAL PRODUCT COMPRISING THE REACTION OF A C1 TO C6 CARBOXYLIC ACID ON A BASIC AMINO ACID
DE3329253A1 (en) * 1983-08-12 1985-02-21 Milupa Ag, 6382 Friedrichsdorf Use of an amino acid mixture for the control of, in particular, lymphadenomas
HU191598B (en) * 1984-03-20 1987-03-30 Egyt Gyogyszervegyeszeti Gyar Method for the preparation of injection solution suitable preferably against cathosis
DE3440090A1 (en) * 1984-11-02 1986-05-07 Novo-Med AG, Appenzell MEDICINAL SOLUTION CONTAINING AMINOSAUR SOLUTIONS FOR THE TREATMENT OF CANCER DISEASES AND METHOD FOR THE PRODUCTION THEREOF
IL77629A (en) * 1985-01-22 1989-07-31 Abbott Lab High fat,low carbohydrate enteral nutritional for mula
FR2591893B1 (en) * 1985-12-19 1988-11-10 Centre Nat Rech Scient METHIONINE-DEFECTED NUTRITIONAL COMPOSITIONS FOR INHIBITING THE DEVELOPMENT AND DISSEMINATION OF MALIGNANT TUMORS IN MAMMALS
US5162373A (en) * 1986-01-17 1992-11-10 Board Of Regents, The University Of Texas System Methods and improved formulations for the determination and treatment of malignant disease in patients
US5189025A (en) * 1988-12-09 1993-02-23 Board Of Regenets, The University Of Texas System Methods for the treatment of malignant disease in patients using citrulline containing amino acid solutions
GB8917660D0 (en) * 1989-08-02 1989-09-20 Rana Ashok S J Prophylaxis of transurethral resection reactions
TW394686B (en) * 1991-10-07 2000-06-21 Otsukapharmaceutical Co Ltd An enteral feeding nutritional composition having anticancer effects
US5658895A (en) * 1991-10-07 1997-08-19 Otsuka Pharmaceutical Factory, Inc. Anticancer enteral feeding composition
DE4228897A1 (en) * 1992-08-29 1994-03-03 Wella Ag Hair setting agent based on lignin or lignin derivatives and dihydroxypropyllignin
EP1287830B1 (en) * 1992-11-19 2009-08-26 Anticancer, Inc. Use of methioninase as an antitumor agent in anti-methionine chemotherapy
HU213677B (en) * 1993-11-09 1997-12-29 Immunal Kft Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
AU716906B2 (en) * 1996-07-30 2000-03-09 Novartis Nutrition Ag Amino acid composition and use thereof in treating tumor growth and metastasis
EP1068868A3 (en) * 1997-07-08 2001-01-31 Rath, Matthias, Dr. med. Synergistic compositions comprising ascorbate and lysine for states related to extracellular matrix degeneration
ES2258426T3 (en) * 2000-06-16 2006-09-01 Matthias Dr. Med. Rath COMPOSITION FOR THE PREVENTION OF DISEASES OF SMOOTH MUSCLES THAT INCLUDE ASCORBATE, ARGININE AND MAGNESIUM.
ES2261136T3 (en) * 2000-10-09 2006-11-16 Matthias Dr. Med. Rath THERAPEUTIC COMPOSITION OF ASCORBATE WITH LISINE AND ARGININE FOR THE PREVENTION AND TREATMENT OF CANCER.
CH694549A5 (en) 2001-01-16 2005-03-31 Dr Matthias Rath A composition comprising an ascorbate and a fibrinolysis inhibitor for treating diseases associated with extracellular matrix degradation e.g. arteriosclerosis, cancer, inflammations and infections
US6686340B2 (en) 2001-06-19 2004-02-03 Matthias Rath Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells
SG106614A1 (en) * 2001-06-21 2004-10-29 Matthias Rath Dr Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
WO2003030890A1 (en) * 2001-10-05 2003-04-17 Tetsuro Asao Immune system activators
US20030105104A1 (en) * 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
US20050053664A1 (en) 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
JP2007529554A (en) * 2004-03-19 2007-10-25 プロ−ファーマシューティカルズ，インク． Composition using multivalent ligand-linked carbohydrate polymer, and targeted therapy of metastatic tumor by the composition
WO2007016952A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced esophagenal and oropharyngolaryngeal cancer
WO2007016949A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced neuropathy
AU2006278823B2 (en) * 2005-07-29 2011-05-12 Tima Foundation Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases
WO2007016950A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced neurodegenerative disease
WO2007016951A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced pancreatic cancer
WO2007016955A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Alcohol metabolism moderating composition
WO2007016954A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing drug or alcohol induced breast cancer risk
WO2008119077A1 (en) 2007-03-28 2008-10-02 University Of Southern California Induction of differential stress resistance and uses thereof
US8865646B2 (en) 2007-03-28 2014-10-21 University Of South California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
JP2011523626A (en) * 2008-04-24 2011-08-18 ユニバーシティー オブ サウザン カリフォルニア，ユーエスシー スティーブンズ Dietary compositions and methods for protecting against chemotherapy, radiation therapy, oxidative stress, and aging
TWI551288B (en) * 2011-02-17 2016-10-01 Ea Pharma Co Ltd Antimicrobial activity enhancer for chemotherapeutic agents
JP2016117702A (en) * 2014-12-22 2016-06-30 武輝 山田 Method for destroying cancer cells
JOP20190146A1 (en) 2016-12-19 2019-06-18 Axcella Health Inc Amino acid compositions and methods for the treatment of liver diseases
KR20200039748A (en) 2017-08-14 2020-04-16 악셀라 헬스 인크. Amino acid composition for treatment of liver disease
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
IT202000000454A1 (en) * 2020-01-13 2021-07-13 Professional Dietetics Spa COMPOSITIONS INCLUDING AMINO ACIDS FOR THE PREVENTION AND TREATMENT OF CANCER

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT297935B (en) * 1968-05-09 1972-04-10 Astra Ab Process for the preparation of an infusion solution of essential amino acids for intravenous delivery in uremic conditions
SU423304A3 (en) * 1970-03-10 1974-04-05 Тейзо Хигаси, Дзинносуке Лбе, Теруо Таке, Сусуми Ватанабе , Масару Отани
DE2013026C3 (en) * 1970-03-19 1981-01-29 Wagner, Karl-Heinz, Prof. Dr.Med.Habil., 6300 Giessen Agents for the treatment and prevention of liver diseases and muscular insufficiency
DE2530246A1 (en) * 1975-07-07 1977-01-13 Fresenius Chem Pharm Ind L-AMINO ACID MIXTURES FOR PARENTERAL OR ORAL USE
DE2531204A1 (en) * 1975-07-12 1977-01-13 Fresenius Chem Pharm Ind L-AMINO ACID MIXTURES FOR PARENTERAL OR ORAL USE

Also Published As

Publication number Publication date
SE448679B (en) 1987-03-16
FR2434622A1 (en) 1980-03-28
CH642541A5 (en) 1984-04-30
AU526207B2 (en) 1982-12-23
GB2029220B (en) 1983-03-30
IT1194844B (en) 1988-09-28
NL190266B (en) 1993-08-02
SE7907316L (en) 1980-03-05
AU5036879A (en) 1980-03-13
DE2935709C2 (en) 1986-02-06
GB2029220A (en) 1980-03-19
IT7905216A0 (en) 1979-09-03
CA1134275A (en) 1982-10-26
DE2935709A1 (en) 1980-03-13
NL7906620A (en) 1980-03-06
JPS6154007B2 (en) 1986-11-20
JPS5535049A (en) 1980-03-11
NL190266C (en) 1994-01-03

Similar Documents

Publication Publication Date Title
DE2938588C3 (en)
DE2834582C3 (en)
FR2415162B1 (en)
DE2914088C2 (en)
DE2819622C2 (en)
DE2954438A1 (en)
DE2831401C2 (en)
DE2852500C2 (en)
FR2415189B1 (en)
FR2414940B1 (en)
FR2406396B1 (en)
DE2829561C2 (en)
FR2414544B1 (en)
DE2838041C2 (en)
FR2414486B1 (en)
DK219978A (en)
AU73950S (en)
BG26014A1 (en)
BG25971A1 (en)
BG26216A1 (en)
BG26097A1 (en)
BG26022A1 (en)
BG26017A1 (en)
BG26015A1 (en)
BG25940A1 (en)